Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Quarterly results Appointed director
|
Statera Biopharma, Inc. (CBLI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/05/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/22/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
04/29/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
04/14/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
03/07/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
03/06/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
02/22/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
02/23/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
02/27/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
03/17/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
04/30/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
03/18/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
03/13/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
03/15/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
03/22/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
03/30/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
03/21/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
|
|